LETTER
Synthesis of 3-Pyrrolines
1287
1713, 1604, 1584, 1506, 1469, 1451, 1433, 1245, 1198,
1169, 1080, 1060 cm–1. MS (ES+): m/z (%) = 522 (100)
[pyrroline 9f + Na]+.
Acknowledgment
A. Soret thanks the French Ministry of Education and Research for
a grant. The authors express their thanks to Abdelkrim Meddour
(ICMMO) for the discussions about NMR results.
(9) Trimethyl (1S*,3S*,3aR*,4S*,7R*,7aS*)-4-[4-(Benzyl-
oxy)phenylmethyl]-1-methyl-3-phenyl-2,3,3a,4,7,7a-
hexahydro-1H-4,7-epoxyisoindole-1,3a,7a-tri-carboxy-
late (7b)
References and Notes
Oil. 1H NMR (400 MHz, CDCl3): d = 1.62 (s, 3 H), 1.96 (d,
J = 14.8 Hz, 1 H), 2.37 (d, J = 14.8 Hz, 1 H), 3.63 (s, 3 H),
3.91 (s, 3 H), 3.94 (s, 3 H), 4.21 (br s, 1 H), 4.84 (br s, 1 H),
4.94 (s, 2 H), 5.71 (s, 1 H), 5.94 (d, J = 5.2 Hz, 1 H), 6.45 (d,
J = 5.2 Hz, 1 H), 6.74 (d, J = 8.8 Hz, 2 H), 6.89 (d, J = 8.8
Hz, 2 H), 7.24–7.60 (m, 10 H). 13C NMR (100 MHz, CDCl3):
d = 21.3, 34.9, 51.7, 52.4, 52.6, 65.7, 69.2, 69.7, 69.9, 80.9,
83.0, 96.7, 113.9, 127.2, 127.6, 127.7, 128.2, 128.3, 130.3,
130.4, 130.8, 132.0, 136.9, 137.3, 145.4, 156.9, 169.3,
171.7, 171.9. IR (neat): 3450, 3062, 3032, 3003, 2951, 1744,
1726, 1654, 1611, 1511, 1454, 1434, 1249, 1225, 1079 cm–1.
MS (ES+): m/z (%) = 274 (33), 334 (100), 598 (15) [M + H]+.
HRMS (ES+): m/z calcd for C35H36O8N: 598.2435; found:
598.2453.
(1) Soret, A.; Blanco, L.; Deloisy, S. Lett. Org. Chem. 2006, 3,
648.
(2) Blanco, L.; Bloch, R.; Bugnet, E.; Deloisy, S. Tetrahedron
Lett. 2000, 41, 7875.
(3) (a) Anderson, W.; Kinder, F. R. J. Heterocycl. Chem. 1990,
27, 975. (b) Komatsu, M.; Ohno, M.; Tsuno, S.; Ohshiro, Y.
Chem. Lett. 1990, 575. (c) Grigg, R.; Gunaratne, N. H. Q.;
Kemp, J. Tetrahedron 1990, 46, 6467.
(4) For a solid-phase application of this methodology, see:
Komatsu, M.; Okada, H.; Akaki, T.; Oderaotoshi, Y.;
Minakata, S. Org. Lett. 2002, 4, 3505.
(5) (a) Pandey, G.; Banerjee, P.; Gadre, S. R. Chem. Rev. 2006,
106, 4484. (b) Husinec, S.; Savic, V. Tetrahedron:
Asymmetry 2005, 16, 2047. (c) Najara, C.; Sansano, J. M.
Curr. Org. Chem. 2003, 7, 1105. (d) Harwood, L. M.;
Vickers, R. J. In The Chemistry of Heterocyclic Compounds,
Vol. 59; Padwa, A.; Pearson, W. H., Eds.; John Wiley and
Sons: New York, 2002, 169–252. (e) Broggini, G.; Zecchi,
G. Synthesis 1999, 905. (f) Grigg, R.; Sridharan, V. In
Advances in Cycloaddition, Vol. 3; Curran, O. P., Ed.; JAI
Press: Greenwich CT, 1993, 161–204.
(10) Trimethyl (2S*,5S*)-2-Methyl-5-phenyl-2,5-dihydro-
1H-pyrrole-2,3,4-tricarboxylate (9b)
White solid; mp 62–63 °C. 1H NMR (400 MHz, CDCl3):
d = 1.66 (s, 3 H), 2.74 (br s, 1 H), 3.60 (s, 3 H), 3.80 (s, 3 H),
3.83 (s, 3 H), 5.35 (s, 1 H), 7.20–7.35 (m, 5 H). 13C NMR
(100 MHz, CDCl3): d = 24.8, 52.2, 52.4, 52.9, 69.0, 73.0,
127.4, 128.3, 128.4, 140.1, 140.9, 141.2, 163.5, 163.7,
172.9. IR (KBr): 3359, 2992, 2950, 2832, 1733, 1715, 1656,
1449, 1433, 1334, 1244, 1204 cm–1. MS (ES+): m/z
(%) = 274 (74), 334 (77) [M + H]+, 356 (100) [M + Na]+.
HRMS (ES+): m/z calcd for C17H19O6NNa: 356.1105; found:
356.1119.
(6) (a) Grigg, R.; Montgomery, J.; Somasunderam, A.
Tetrahedron 1992, 48, 10431. (b) Nyerges, M.; Rudas, M.;
Tòth, G.; Herényi, B.; Kàdas, I.; Bitter, I.; Töke, L.
Tetrahedron 1995, 51, 13321.
(11) Trimethyl (2S*,5S*)-2-[4-(Benzoyloxy)phenylmethyl]-5-
phenyl-2,5-dihydro-1H-pyrrole-2,3,4-tricarboxylate (9f)
Oil. 1H NMR (250 MHz, CDCl3): d = 2.83 (br s, 1 H), 3.32
(s, 2 H), 3.54 (s, 3 H), 3.80 (s, 3 H), 3.90 (s, 3 H), 4.68 (br s,
1 H), 7.14 (d, J = 8.5 Hz, 2 H), 7.26–7.30 (m, 5 H), 7.42 (d,
J = 8.5 Hz, 2 H), 7.46–7.52 (m, 2 H), 7.57–7.67 (m, 1 H),
8.20 (d, J = 7.0 Hz, 2 H). 13C NMR (62.9 MHz, CDCl3):
d = 42.5, 52.0, 52.5, 52.8, 69.1, 77.5, 121.1, 127.7, 128.1,
128.5, 128.6, 129.5, 130.0, 131.8, 133.1, 133.5, 140.4,
140.7, 141.1, 150.0, 162.7, 164.5, 165.0, 171.9. IR (neat):
3367, 3063, 3032, 3005, 2953, 2847, 1739, 1731, 1713,
1659, 1601, 1507, 1452, 1434, 1250, 1200, 1168, 1082,
1063, 1024 cm–1. MS (ES+): m/z (%) = 552 (100) [M + Na]+.
HRMS (ES+): m/z calcd for C30H27O8NNa: 552.1629; found:
552.1628.
(7) Trimethyl (1S*,3S*,3aR*,4R*,7S*,7aS*)-7-[4-(Benzyl-
oxy)phenylmethyl]-3-phenyl-2,3,3a,4,7,7a-hexahydro-
1H-4,7-epoxyisoindole-1,3a,7a-tricarboxylate (4a)
White solid; mp 106 °C. 1H NMR (400 MHz, CDCl3):
d = 2.93 (s, 3 H), 3.25 (d, J = 15.2 Hz, 1 H), 3.48 (d, J = 15.2
Hz, 1 H), 3.81 (s, 3 H), 3.86 (s, 3 H), 4.41 (s, 1 H), 4.45 (s, 1
H), 4.95 (s, 1 H), 5.07 (s, 2 H), 6.15 (d, J = 6.0 Hz, 1 H), 6.66
(d, J = 6.0 Hz, 1 H), 6.96 (d, J = 8.4 Hz, 2 H), 7.27 (d, J = 8.4
Hz, 2 H), 7.29–7.92 (m, 10 H). 13C NMR (100 MHz, CDCl3):
d = 35.0, 51.5, 52.0, 52.4, 66.6, 70.0, 70.1, 73.5, 82.6, 83.9,
94.5, 114.5, 127.2, 127.6, 128.1, 128.4, 128.5, 128.6, 129.3,
131.4, 133.4, 137.2, 137.8, 141.3, 157.6, 169.8, 170.9,
171.2. IR (KBr): 3307, 1744, 1731, 1609, 1581, 1511, 1452,
1431, 1245, 1222, 1106 cm–1. MS (ES+): m/z (%) = 320
(100) [pyrroline 10 + H]+, 342 (16) [pyrroline 10 + Na]+.
Anal. Calcd for C34H33NO8: C, 69.97; H, 5.70; N, 2.40.
Found: C, 69.81; H, 5.67; N, 2.27.
(12) Trimethyl (3S*,4S*,5R*)-5-Phenyl-4,5-dihydro-3H-
pyrrole-2,3,4-tricarboxylate (10)
Oil. 1H NMR (400 MHz, CDCl3): d = 3.15 (s, 3 H), 3.76 (s,
3 H), 3.87 (dd, J = 9.2, 6.0 Hz, 1 H), 3.93 (s, 3 H), 4.72 (dd,
J = 6.0, 2.4 Hz, 1 H), 5.86 (dd, J = 9.2, 2.4 Hz, 1 H), 7.05–
7.08 (m, 2 H), 7.22–7.32 (m, 3 H). 13C NMR (100 MHz,
CDCl3): d = 51.8, 52.7, 52.9, 56.5, 56.6, 78.9, 127.4, 128.2,
128.3, 135.6, 161.9, 164.0, 170.0, 170.1. IR (neat): 3059,
3033, 3007, 2956, 2919, 2847, 1726, 1648, 1452, 1437,
1369, 1312, 1258, 1217, 1101 cm–1. MS (ES+): m/z (%) =
260 (100), 342 (82) [M + Na]+. HRMS (ES+): m/z calcd for
C16H17O6NNa: 342.0948; found: 342.0955.
(8) Trimethyl (1S*,3S*,3aR*,4S*,7R*,7aS*)-1-[4-(Benzoyl-
oxy)phenylmethyl]-4-[4-(benzyloxy)phenylmethyl]-3-
phenyl-2,3,3a,4,7,7a-hexahydro-1H-4,7-epoxyisoindole-
1,3a,7a-tricarboxylate (7f)
Oil. 1H NMR (250 MHz, CDCl3): d = 1.95 (d, J = 15.0 Hz, 1
H), 2.40 (d, J = 15.0 Hz, 1 H), 3.09 (d, J = 14.0 Hz, 1 H),
3.49 (d, J = 14.0 Hz, 1 H), 3.73 (s, 3 H), 3.84 (s, 3 H), 3.99
(s, 3 H), 4.77 (d, J = 1.8 Hz, 1 H), 4.94 (s, 2 H), 5.97 (br s, 1
H), 6.00 (dd, J = 5.5, 1.8 Hz, 1 H), 6.49 (d, J = 5.5 Hz, 1 H),
6.75 (d, J = 8.8 Hz, 2 H), 6.90 (d, J = 8.8 Hz, 2 H), 7.04 (d,
J = 8.5 Hz, 2 H), 7.31–7.60 (m, 15 H), 8.15 (d, J = 7.0 Hz, 2
H). 13C NMR (62.9 MHz, CDCl3): d = 35.1, 37.1, 52.1, 52.5,
52.8, 65.2, 69.8, 70.8, 74.4, 81.7, 83.6, 96.9, 114.1, 120.9,
127.4, 127.7, 127.8, 127.9, 128.1, 128.5, 130.1, 130.4,
131.0, 131.6, 131.8, 132.5, 133.2, 133.3, 133.4, 137.1,
137.4, 145.6, 149.6, 157.1, 165.0, 169.5, 170.6, 172.9. IR
(neat): 3327, 3060, 3028, 3005, 2951, 2851, 1738, 1729,
(13) Katritzky, A. R.; Hitchings, G. J.; Zhao, X. Synthesis 1991,
863.
(14) Trimethyl (2S*,5S*)-1-(Phenylcarbamoyl)-5-phenyl-2,5-
dihydro-1H-pyrrole-2,3,4-tricarboxylate (11)
White solid; mp 156–157 °C. 1H NMR (250 MHz, CDCl3):
d = 3.69 (s, 3 H), 3.86 (s, 3 H), 3.93 (s, 3 H), 5.60 (d, J = 3.0
Hz, 1 H), 5.96 (d, J = 3.0 Hz, 1 H), 6.76 (br s, 1 H), 6.99 (t,
Synlett 2007, No. 8, 1284–1288 © Thieme Stuttgart · New York